Delivery Order SPE2DB22D2007-SPE2DB24FH9LZ

Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $6.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award is to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 10 mg Rosuvastatin Calcium tablets in 1,000 count packages for the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price, with a potential value of $7,037.11, and a completion date of February 7, 2024. This is a delivery order contract, not subject to any set-aside requirements. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC)...
This federal contract award is for the delivery of Rosuvastatin Calcium 40 mg tablets to the Defense Logistics Agency (DLA). The $38,713.69 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical division. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,509.60 firm fixed-price delivery order is for the supply of 4,563,731,412 units of Rosuvastatin Calcium 20 mg tablets. The contract has a period of performance through February 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $26,964.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, with a period of performance through December 2023. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Rosuvastatin Calcium 40 mg tablets. The $203,677.65 firm-fixed-price delivery order contract has a period of performance through May 9, 2023. No set-aside designation was used for this award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,668.55 firm fixed-price delivery order contract covers the supply of 500 count bottles of 5 mg Rosuvastatin Calcium tablets. The contract has an ultimate completion date of July 30, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,470.48, is for the delivery of rosuvastatin calcium 5 mg tablets. The award date is February 16, 2024, with a completion date of February 20, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen is an established DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $17,020.10 delivery order is for Rosuvastatin Calcium 5 mg tablets, a cardiovascular medication. This award falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.80 firm fixed-price delivery order contract covers the supply of 4,563,434,855 units of Rosuvastatin Calcium 40 mg tablets with a completion date of January 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM42E, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,485.50 delivery order contract is for the supply of 4,563,458,779 units of Rosuvastatin Calcium 40 mg tablets, with a completion date of January 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FH9LZ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the provision of Rosuvastatin Calcium 5 mg tablets in 500 count packages. The $6,532.20 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) and has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has been awarded numerous similar pharmaceutical and medical supply contracts by DLA to support military treatment programs and facilities. The contract does not have a set-aside designation.

Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of medications and healthcare materials to DLA Troop Support Medical facilities supporting the Department of Defense. This single award IDC does not fall under any overarching contract vehicles and was awarded solely to Amerisourcebergen Drug Corp.

Generated 5/10/24, 10:22 AM